Goldfischer Carl
SEC-identified person · CIK 1110780 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Galecto, Inc. GLTO | Director | filed 2020 - 2025 |
| Epizyme, Inc. EPZM | Director | filed 2013 - 2022 |
| Imara Inc. IMRA | Director | filed 2020 - 2022 |
| Cymabay Therapeutics, Inc. CYMA | Director | filed 2013 - 2019 |
| Reshape Weightloss Inc. etrm | Director | filed 2007 - 2017 |
| Poniard Pharmaceuticals, INC. PARD | Director | filed 2006 - 2011 |
| MAP Pharmaceuticals, Inc. MAPP | Director | filed 2007 - 2010 |
| Zvue Corp zvue | Director | filed 2006 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.